Theramx -AI-Based Brainwave Diagnosis (EEG) Technology
Technology that excavates biomarkers through an analysis of brainwaves in epilepsy or Alzheimer’s patients, predicts the likelihood of onset, or diagnoses the advance, based on the degree of change of brainwave biomarkers measured by a wearable EEG (AI-electroencephalogram) measuring instrument allowing.
Theramx retains AI-based technology that allows brainwave analysis for prediction, diagnosis of epilepsy or Alzheimer and discovery of biomarkers, as well as development competency for AI-based prediction software. Based on such proficiency, Theramx is developing AI-prediction software interface and non-invasive wearable EEG device optimized for epilepsy and Alzheimer’s biomarkers, distinguished from the conventional device which is limited to detective functions only.
